Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
about
Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus FungiSexual development and cryptic sexuality in fungi: insights from Aspergillus speciesFungal Aflatoxins Reduce Respiratory Mucosal Ciliary Function.Health economic impacts and cost-effectiveness of aflatoxin-reduction strategies in Africa: case studies in biocontrol and post-harvest interventionsKeratitis due to Aspergillus flavus: clinical profile, molecular identification of fungal strains and detection of aflatoxin production.Evaluating the technical feasibility of aflatoxin risk reduction strategies in AfricaA study on trypsin, Aspergillus flavus and Bacillus sp. protease inhibitory activity in Cassia tora (L.) syn Senna tora (L.) Roxb. seed extract.Two new aflatoxin producing species, and an overview of Aspergillus section FlaviSusceptibility of Candida species and various moulds to antimycotic drugs: use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey.Simple and highly discriminatory VNTR-based multiplex PCR for tracing sources of Aspergillus flavus isolates.RNA-Seq-based transcriptome analysis of aflatoxigenic Aspergillus flavus in response to water activity.Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.Prevalence of fungal infection among Iranian patients with chronic sinusitis.MALDI-TOF mass spectrometry: any use for Aspergilli?Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan.Co-infection of invasive pulmonary aspergillosis and cutaneous Fusarium infection in a patient with pyoderma gangrenosum.Functional Genomic Analysis of Aspergillus flavus Interacting with Resistant and Susceptible Peanut.Conventional Morphology Versus PCR Sequencing, rep-PCR, and MALDI-TOF-MS for Identification of Clinical Aspergillus Isolates Collected Over a 2-Year Period in a University Hospital at Kayseri, Turkey.The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis.Effects of Nutrients in Substrates of Different Grains on Aflatoxin B1 Production by Aspergillus flavus.Aspergillus-associated airway disease, inflammation, and the innate immune responseLaboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcomePharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis.A review molecular typing methods for Aspergillus flavus isolates.Invasive aspergillosis in children with hematological malignancies.Proteomics of eukaryotic microorganisms: The medically and biotechnologically important fungal genus Aspergillus.Efficacy and safety of current drug therapies for invasive aspergillosis.Invasive aspergillosis: resistance to antifungal drugs.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.A fucose specific lectin from Aspergillus flavus induced interleukin-8 expression is mediated by mitogen activated protein kinase p38.Characteristics of invasive aspergillosis in neutropenic haematology patients (Sousse, Tunisia).Microsatellite typing to trace Aspergillus flavus infections in a hematology unitGenotyping of clinical and environmental Aspergillus flavus isolates from Iran using microsatellites.Development of a Dot-Blot Assay for the Detection of Mould-Specific IgE in the Belgian Population.Molecular variation analysis of Aspergillus flavus using polymerase chain reaction-restriction fragment length polymorphism of the internal transcribed spacer rDNA region.Recurrent Fungal Keratitis and Blepharitis Caused by Aspergillus flavusA Novel Y319H Substitution in CYP51C Associated with Azole Resistance in Aspergillus flavus.Could Histoplasma capsulatum Be Related to Healthcare-Associated Infections?In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia.The Utilization of RNA Silencing Technology to Mitigate the Voriconazole Resistance of Aspergillus Flavus; Lipofectamine-Based Delivery.
P2860
Q28068091-D47C6AB3-3950-47C6-8AB1-7B8F95FC43FBQ28253241-EDEE0015-A35A-4CAD-BC3F-F0018BE8D279Q30810957-B1ACF0BE-A748-4441-A05E-FF2AAB77CEBAQ33805854-1A3CBFD2-4011-48F3-999D-47FF6211829FQ33837387-7D173019-3563-4858-847E-3B2738698807Q33901917-6AB71119-BCFF-4CC7-8474-B946DCCAE2F9Q33958779-7E1F1C8D-F621-4521-8957-C1FBC3C5D917Q34011033-1E5A3A88-9632-4DDD-97DB-42B84FEB8654Q34187936-156A89DB-F1C5-4A04-BDBC-8F9258306E81Q34426975-18F3E3F1-516A-4D86-B6FA-C2EAC0EA7984Q34585013-9A1CFB99-FD6C-4874-94CE-D3982329368EQ34621506-9ADAF60C-E771-4A77-9DCC-7A88D1FA02E0Q35135958-3BC6F70A-CB18-4ED6-B2A6-D6F9DB114604Q35202737-0599A969-7BDA-4BEF-A2A1-EBA24CC2D194Q35386894-5D1A44EC-02C5-4657-AE98-4A0588B11F3EQ35454815-963CD581-AEEA-4484-9D1E-CF496F2F2D95Q35927535-29C29312-BFCE-4F57-9F80-0D0036308BE1Q35939584-AE3E5576-822E-4D18-BF85-4B710D52A738Q35941367-3F8E6D4C-DE78-42A2-9F81-BD0D176765D8Q36949083-55DACBF3-5733-4D16-865E-16727CAA028CQ37077782-E196FBAC-ADAB-419A-8618-29F5AF51D673Q37287794-2D34AF5C-168D-481F-87C5-C4FEDB7DF795Q37538782-95F31702-C44F-43B7-ADED-BD134A9BD522Q37849192-1192377F-9173-4311-9857-5B60F5E92C28Q37854719-C878C979-D634-4796-8320-F2489B93C95DQ37897213-F5F0F481-D6CD-43A7-88D0-F50BA99E30B5Q37944001-DC177A47-987D-4AD9-A402-AFCDD9188DC5Q37983464-FAA9A32A-1BD1-4336-92DC-46F90263E221Q38711698-D332FECF-6F6A-48FE-AB6D-644AC9A074E2Q38744031-E3865E8E-3F65-4BC6-9BA8-3E60FA051C58Q39022120-D4CBA788-F83F-42AC-91AE-EAAAB8CCC044Q39040647-E26BAC45-16F8-46FB-8705-ACEABA1D5F28Q39134140-BE85D9FA-444E-4C6C-9DEC-A5C950F20FDDQ39160428-FDDE572B-E1A3-42E5-A390-9E1EF01058D7Q39623156-A99915D8-01E1-422E-B94F-0AB9A0A3736BQ40469147-C3F270FC-65B3-4560-A87F-112453FE8888Q40653596-4FB498F5-F082-43E4-814A-303A15C50B58Q41142605-468074B0-279D-4762-A2E5-42E80364EA68Q41282603-65E236E4-B4A6-463C-B967-3114E1BD36E6Q41771967-ECFC0BBA-2D48-4E89-81FB-89FBE52FC204
P2860
Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
@en
Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
@nl
type
label
Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
@en
Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
@nl
prefLabel
Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
@en
Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
@nl
P2093
P2860
P1433
P1476
Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
@en
P2093
Elias K Manavathu
Pranatharthi H Chandrasekar
Suganthini Krishnan
P2860
P304
P356
10.1111/J.1439-0507.2008.01642.X
P577
2009-01-14T00:00:00Z